News & Insights
Sort By
Insights 2 Results
Insights
|March 23, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure’s article, "The Legal Playbook for Building a Biotech Company, From Formation to Financing," which discusses how a biotech company’s legal needs shift quickly as it grows and explores how founders can build the right legal foundation, avoid common missteps, and bring in the right counsel at the right time.
Insights
|March 11, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure's article, "Technology Transfer in Biotech and Pharma and the Process of Scaling New Medicines," which explains how technology transfer works in biotech and pharma, the different types of transfers, and why poor execution can delay commercialization.
Events 4 Results
Events
|October 27-28, 2025
Gunderson Dettmer Sponsors the Longwood Healthcare Leaders Boston CEO Summit 2025
Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions
Events
|October 16, 2025
“What’s Next in Biotech” In Conversation with Venrock Partner Bryan Roberts
Watch the Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Managing Partner Bryan Roberts
Events
|December 4, 2024
One Nucleus Hosts Genesis 2024 Conference
Gunderson Dettmer partner, Tim Ehrlich, to moderate a panel at the annual Genesis London Conference
Client News 80 Results
Client News
|October 6, 2026
Hims & Hers Co-Leads Arboretum’s $30 Million Series A
Hims & Hers leads Arboretum LifeSciences’ $30 million Series A financing.
Client News
|September 9, 2026
Leyden Labs Acquires RIGImmune
RIGImmune announces its acquisition by Leyden Labs.
Client News
|September 8, 2026
BrainChild Bio Closes $116 Million Series A
BrainChild Bio announces its $116 million Series A financing.
Firm News 13 Results
Firm News
|August 27, 2026
As part of its annual list of Massachusetts legal industry leaders, Massachusetts Lawyers Weekly (MLW) has once again recognized Boston partner and Life Sciences practice group chair Tim Ehrlich as a Go To Lawyer in the Health Care and Life Sciences practice area.
Firm News
|August 18, 2026
PitchBook’s Q2 2026 Global League Tables once again recognize Gunderson Dettmer as the most active venture capital law firm worldwide.
Firm News
|January 12, 2026
Richard Chang Recognized Again in China Business Law Journal’s The A-List 2025-26: Growth Drivers
Richard Chang, Corporate Partner and Head of Gunderson Dettmer’s Beijing office, has once again been named to China Business Law Journal’s A-List as China’s 2025-26 Growth Drivers Elite International Lawyers.